Jonas Larsson

Title: Innovations and Contributions of Inventor Jonas Larsson

Introduction

Jonas Larsson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biotechnology, particularly in the areas of genetic sequencing and stem cell research. With a total of 2 patents, his work has the potential to impact medical treatments and genetic analysis.

Latest Patents

Jonas Larsson's latest patents include innovative methods for determining the frequency distribution of nucleotide sequence variants. This patent discloses a process for generating a reference set of sequence read data and determining the detectability of intermediate parts of sequence reference variants. Additionally, he has developed methods for the expansion of hematopoietic stem and progenitor cells (HSPC) both ex vivo and in vivo. These methods aim to enhance the treatment of anemia in human subjects by utilizing inhibitors of serine threonine kinase 38 (STK38).

Career Highlights

Throughout his career, Jonas has worked with prominent organizations, including The General Hospital Corporation and Tigerq AB. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Jonas has collaborated with esteemed colleagues such as David T. Scadden and David Yudovich. These partnerships have further enriched his research and contributed to advancements in his field.

Conclusion

Jonas Larsson's innovative work in biotechnology and his contributions to genetic research and stem cell expansion highlight his importance as an inventor. His patents reflect a commitment to advancing medical science and improving patient care.